Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Apple
AAPL
|
$2.4B |
| 2 |
Eaton
ETN
|
$1.08B |
| 3 |
Analog Devices
ADI
|
$927M |
| 4 |
Progressive
PGR
|
$786M |
| 5 |
Datadog
DDOG
|
$742M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.77B |
| 2 |
UnitedHealth
UNH
|
$1.76B |
| 3 |
Advanced Micro Devices
AMD
|
$1.21B |
| 4 |
Salesforce
CRM
|
$1.17B |
| 5 |
lululemon athletica
LULU
|
$996M |
Sector Composition
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
DuPont de Nemours
DD
$32.6B
| $38.7M | 0.02% |
481,298
+48,507
| +11% | +$3.9M |
|
252
Exact Sciences
EXAS
$10.2B
| $38.7M | 0.02% |
915,434
+281,805
| +44% | +$11.9M |
|
253
Darling Ingredients
DAR
$5.07B
| $38.6M | 0.02% |
1,050,595
-512,144
| -33% | -$18.8M |
|
254
LiveRamp
RAMP
$1.86B
| $38.5M | 0.02% |
1,245,755
-161,343
| -11% | -$4.99M |
|
|
AZEK
255
DELISTED
The AZEK Co
AZEK
| $38.3M | 0.02% |
909,484
-3,005
| -0.3% | -$127K |
|
256
GE HealthCare
GEHC
$34.6B
| $37.9M | 0.02% |
486,961
-207,389
| -30% | -$16.2M |
|
257
CoStar Group
CSGP
$37.9B
| $37.7M | 0.02% |
509,151
+200
| +0% | +$14.8K |
|
258
Varonis Systems
VRNS
$6.28B
| $37.5M | 0.02% |
782,289
-369
| -0% | -$17.7K |
|
259
Great Lakes Dredge & Dock
GLDD
$798M
| $37.4M | 0.02% |
4,254,351
-105,374
| -2% | -$925K |
|
260
Celldex Therapeutics
CLDX
$1.52B
| $37.1M | 0.02% |
1,003,085
+315,005
| +46% | +$11.7M |
|
261
Ryan Specialty Holdings
RYAN
$6.96B
| $37M | 0.02% |
639,697
+202,038
| +46% | +$11.7M |
|
262
Kosmos Energy
KOS
$784M
| $36.9M | 0.02% |
6,669,372
+390,619
| +6% | +$2.16M |
|
263
Cameco
CCJ
$33B
| $36.8M | 0.02% |
747,461
+42,167
| +6% | +$2.07M |
|
264
Dorman Products
DORM
$5B
| $36.5M | 0.02% |
399,237
+115,850
| +41% | +$10.6M |
|
265
Hologic
HOLX
$14.8B
| $35.8M | 0.02% |
482,344
+4,243
| +0.9% | +$315K |
|
266
Utz Brands
UTZ
$1.19B
| $34.7M | 0.02% |
2,086,678
+755,097
| +57% | +$12.6M |
|
267
Flywire
FLYW
$1.59B
| $34.7M | 0.02% |
2,114,532
+253,581
| +14% | +$4.16M |
|
268
Xylem
XYL
$34.2B
| $34.6M | 0.02% |
255,450
+29,250
| +13% | +$3.97M |
|
269
Lowe's Companies
LOW
$151B
| $34.5M | 0.02% |
156,510
+49,364
| +46% | +$10.9M |
|
270
Oneok
OKE
$45.7B
| $34.2M | 0.02% |
419,113
-97,010
| -19% | -$7.91M |
|
271
Enpro
NPO
$4.58B
| $33.9M | 0.02% |
232,664
-214,159
| -48% | -$31.2M |
|
272
Bristol-Myers Squibb
BMY
$96B
| $33.9M | 0.02% |
815,466
-250,449
| -23% | -$10.4M |
|
273
Littelfuse
LFUS
$6.51B
| $33.4M | 0.02% |
130,837
+99,117
| +312% | +$25.3M |
|
274
Progyny
PGNY
$1.94B
| $33.4M | 0.02% |
1,167,962
-1,428,460
| -55% | -$40.9M |
|
275
Darden Restaurants
DRI
$24.5B
| $33.4M | 0.02% |
220,650
+13,485
| +7% | +$2.04M |
|